PERIPHERAL BLOOD STEM CELL TRANSPLANTATION
Clinical trials for PERIPHERAL BLOOD STEM CELL TRANSPLANTATION explained in plain language.
Never miss a new study
Get alerted when new PERIPHERAL BLOOD STEM CELL TRANSPLANTATION trials appear
Sign up with your email to follow new studies for PERIPHERAL BLOOD STEM CELL TRANSPLANTATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug cocktail aims to stop leukemia relapse after transplant
Disease control Recruiting nowThis study tests whether adding two drugs (ruxolitinib and chidamide) to the standard chemotherapy before a stem cell transplant can lower the chance of leukemia coming back. It involves 50 people aged 12–65 with high-risk B-cell acute lymphoblastic leukemia who have a suitable d…
Matched conditions: PERIPHERAL BLOOD STEM CELL TRANSPLANTATION
Phase: PHASE2 • Sponsor: Chinese PLA General Hospital • Aim: Disease control
Last updated May 26, 2026 08:30 UTC
-
Could a lower drug dose make stem cell transplants safer?
Disease control Recruiting nowThis study is for people with blood cancers who need a stem cell transplant from a donor. It tests if a lower dose of the drug cyclophosphamide, given right after the transplant, can prevent graft-versus-host disease (a common complication) while causing fewer side effects. Parti…
Matched conditions: PERIPHERAL BLOOD STEM CELL TRANSPLANTATION
Phase: PHASE1, PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 20, 2026 11:57 UTC